Winning and Defending Market Share in MENA Healthcare Markets in 2026

FrontierView is pleased to invite you to join us on Thursday, April 30, for an exclusive discussion.

As policy and market dynamics across MENA continue to evolve in 2026, we will reconvene our executive group in April to take stock of how early-2026 developments are reshaping commercial assumptions and strategic priorities.

The discussion will focus on evolving localization and local value requirements in Saudi Arabia, the regional impact of Most-Favoured Nation (MFN) pricing on pharmaceutical and medtech firms, and ongoing reimbursement and pricing reforms in the UAE, alongside other key policy and market shifts.

Designed for high engagement, the session will:

• Enable participants to stress-test growth and risk scenarios
• Benchmark assumptions with peers
• Refine strategies to sustain commercial outperformance in an increasingly constrained operating environment.